GE HealthCare Technologies Inc.
$73.69-0.1%YTD-14.9%1Y+0.0%
Mentions · last 7 days
43+21%
Price updated 3h ago·X counts updated 1d ago
AI verdict & sentimentAI analysisGenerated by AI from underlying data
Today's AI verdict on what's driving $GEHC, plus how loud the X conversation is and which way it's leaning.
What it does
Plain-English summary of the business — what they sell and how they make money.
Industry overviewAI analysisGenerated by AI from underlying data
Where Medical - Healthcare Information Services sits in its cycle right now — and what that implies for $GEHC.
Medical - Healthcare Information Services
No material change from last week — VEEV's 'agentic commercial' CRM framing converts AI from feature to platform pricing, while TEM's oncology AI platform and pharma data licensing confirm AI..
Industry benchmark
10-name peer basket
+34.5%YTD
+31.4%1Y
Fundamentals & catalyst
Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.
Key ratios
P/E
20.1How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.ROIC
8.1%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.Op margin
12.7%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.FCF yield
2.8%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).P/S
1.6Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.ROE
15.2%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.Gross margin
42.9%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.D/E
0.9Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.Past earnings
QuarterReportedActualEstimateSurprise
Q2 2026Jul 29, 2026$1.13$1.04+8.7%
Q1 2026Apr 29, 2026$0.99$1.04-4.8%
Q4 2025Feb 4, 2026$1.44$1.40+2.9%
Q3 2025Oct 29, 2025$1.07$1.05+1.9%
Next earningsWed, Nov 4·consensus EPS $1.21
Quarterly trend
QuarterRevenueYoYGrossOpEPSFCF
Q2 FY26$5.3B+5.8%41.2%14.0%$1.24$-617.0M
Q1 FY26$5.1B+7.4%38.5%10.0%$0.85$112.0M
Q4 FY25$4.7B-12.1%54.3%14.2%$0.41$917.0M
Q3 FY25$5.1B+5.8%38.7%12.7%$0.98$483.0M
Forward consensus
FYRevenueRangeEPSRangeAnalysts
FY26$21.7B$21.6B – $21.9B$4.91$4.88 – $4.9214
FY27$22.7B$22.4B – $22.9B$5.43$5.20 – $5.5414
FY28$23.8B$23.3B – $24.4B$6.04$5.51 – $6.3716
FY29$25.2B$24.9B – $25.5B$6.68$6.57 – $6.7915
FY30$26.4B$26.1B – $26.8B$7.30$7.19 – $7.4215
Setup & momentum
Volume, range, and moving-average position — the technical setup driving short-term moves.
Right now
Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.4×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.48%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.+12.6%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.+1.2%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.
Float & profile
FloatHigh float · 450.3M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.5% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β0.825-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.
Insider activity
Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.
SEC filings
Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.
Recent material filings
8-KPress release / Reg FDJul 298-K — Item 7.01: Press release / Reg FD
AI summary
8-KOfficer or director changeJul 238-K — Item 2.02: Earnings release · Item 5.02: Officer or director change
AI summary
8-KShareholder voteMay 118-K — Item 5.07: Shareholder vote · Item 8.01: Other event
8-KOfficer or director changeMar 178-K — Item 5.02: Officer or director change · Item 7.01: Press release / Reg FD
8-KAgreement terminatedFeb 278-K — Item 1.01: Material agreement · Item 1.02: Agreement terminated · Item 2.03: Material debt obligation
+ 14 other (6 13Gs · 2 10-Qs · 2 earnings 8-Ks · 2 proxys) in window
Recent news
Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.
GEHC or LMAT: Which Is the Better Value Stock Right Now?GE HealthCare (GEHC) Upgraded to Buy: Here's What You Should KnowGE HealthCare Technologies (GEHC) Just Overtook the 200-Day Moving AverageHere's Why GE HealthCare Technologies (GEHC) is a Strong Momentum StockGE HealthCare: Strong Orders, Innovation Pipeline, And PCS Recovery Point To Growth Inflection
In themes
Explore the broader themes this ticker is being talked about under.
More in Medical - Healthcare Information Services
Peers in the same group — one click to compare setups, fundamentals, and chatter.
Voices on X · top 1 · last 7 days